>>>This, THIS, is a primary example of *why* borders and sovereignty should be
protected.  A<>E<>R <<<

>From  www.wsws.org

WSWS : News & Analysis : Medicine & Health
Drug-resistant tuberculosis threatens millions
By Debra Watson
16 May 2000
Back to screen version

The super-deadly strains of drug-resistant tuberculosis that killed 500 people
in New York City in the early 1990s are now turning up in alarming numbers in
the underdeveloped countries.

Each year over 2 million people, mostly poor, die from the disease. Just 22
countries, designated high burden countries, account for 80 percent of the
world's tuberculosis cases. These include China, India, Bangladesh, Pakistan,
Indonesia, Russia and the Philippines. Of new TB cases, fully 95 percent are in
the underdeveloped world.

One third of the people in the world are believed to carry the tuberculosis
microbe. Of the estimated 2 billion infected, one in ten are expected to
develop active tuberculosis at some time in their lives. The bacterial
infection can live for years in its host, causing chronic debilitation, and is
often fatal. Drug treatment has been available for over 50 years that can
easily kill susceptible strains of the bacteria, yet even at a cost of $10 per
patient in the underdeveloped world, treatment remains out of reach for
millions.

It costs $5,000 per patient to treat the new drug-resistant strains and
multidrug-resistant strains are often incurable even with modern antibiotics.
Drug resistance is a wholly man-made phenomenon. Selective mutation of the
microbe burden in a host results from inadequate or intermittent drug supply
for the patient or from the misuse of available anti-tuberculosis drugs.
Health workers fear that the high cost of treating drug-resistant strains will
be impossible in countries already reeling from several epidemics of infectious
disease as well as social and political factors such as war, massive poverty
and inequality and economic crisis.

"Our biggest worry is that drug-resistant TB will also begin increasing in
other developing countries," said Dr. David Heymann, executive director of
Communicable Diseases for the World Health Organization (WHO). "North America
and Europe may have the billions of dollars required to contain this emergency.
The worst affected countries in Asia, Africa and Latin America do not," Heymann
added. During the five years of the New York City epidemic it cost over $1
billion to treat approximately 3,800 patients and to contain further spread of
the deadly strains in the US.

WHO estimates 50 million people worldwide are already infected with drug-
resistant tuberculosis. There are several “hot spots” in the world where
multidrug-resistant tuberculosis (MDR-TB) makes up more than 3 percent of new
TB cases. Growing numbers of drug-resistant tuberculosis cases apparently are
being contracted directly through breathing the same air as a person already
sick from a resistant strain. Researchers believe a person with TB infects
another 10 to 15 people each year he remains ill.

In Estonia nearly 37 percent of new TB cases were resistant to at least one
drug. Resistance to all four drugs tested was 8.5 percent among new
tuberculosis patients there and the country also had the highest level of MDR-
TB of any area of the world in TB patients who had never before been
treated—14.1 percent. MDR-TB is defined as resistance to at least the drugs
Isoniazid and Rifampicin.

MDR-TB in new cases was also found in large numbers in Henan province in China,
10.8 percent and Latvia, 9 percent. In Russia in Ivanovo Oblast it was also 9
percent and in Tomsk Oblast it was 6.5 percent, well above the global median of
1 percent. Iran also had high levels, 5.8 percent of new tuberculosis cases
were resistant to at least two drugs.

Estonia is also a documented example of increasing levels of drug resistance.
In 1998 the percentage of patients with MDR-TB who had been previously treated
for tuberculosis was 37.8 percent, up from 19.2 percent in 1994.

Anti-tuberculosis drug-resistance in the world, Report No. 2 follows up on a
1997 report from WHO and the International Union Against Tuberculosis and Lung
Disease. Researchers now warn that unchecked epidemics in underdeveloped
countries will spill over into more affluent countries. Already in the earlier
report they documented cases of MDR-TB in every one of 35 geographical areas
surveyed between 1994 and 1996, and on every continent.

Transnational tuberculosis, spread across the world in human hosts via global
travel, is suspected as the cause of rising drug-resistant TB and the more
dangerous multidrug-resistant TB in Europe and other countries with few overall
cases. In Germany and Denmark the percentage of TB patients resistant to a
single drug has increased by 50 percent since 1996. It doubled in one year in
New Zealand. Germany is currently treating over 100 cases of MDR-TB.

MDR-TB was not found to be any more prevalent among immigrants than in natives
of low-incidence countries. However in Israel there was significantly higher
incidence of MDR-TB found among immigrants than in the settled population,
which indicated to researchers that the source was immigration from countries
where MDR-TB is already epidemic.

The report also notes: "A similar explanation has been offered in the case of
Iran, suggesting that most foreign-born patients are from countries with
political turmoil, war and lack of proper TB control, and therefore bear a
possibly high MDR-TB burden." The authors of the report go on to point out that
these are also among the factors causing people to emigrate, and the dangers of
MDR-TB epidemics spreading globally is exacerbated by such adverse conditions.

MDR-TB in the former Soviet Union

The leading source of MDR-TB in Western Europe is thought to be the epidemic in
the countries once part of the Soviet Union, and medical personnel work in a
crisis of epic proportion in parts of Russia. In Russia the total cases of TB
were estimated to be over 150,000 in 1998.

Another report entitled The Global Impact of Drug-Resistant Tuberculosis was
commissioned by the Open Society Institute and was prepared by Harvard Medical
School. In the 1999 report the authors commented: "In North America and Europe
the resurgence is linked to reduction in, or dismantling of, public health
services; an increase in the number of the urban poor and homeless; immigration
from high prevalence countries; and, in some cases, the HIV epidemic."

According to the Harvard report, the severe economic crisis in countries of the
former Soviet Union brought these factors to acute levels, reversing the
spectacular decline in TB in the Soviet Union since the 1917 revolution. They
noted: "Whatever their long-term merits, far-reaching social and economic
changes have in the short term dealt severe blows to Russia's large medical and
public-health systems, leading in turn to decreased capacity to deal with the
country's most significant health crises in decades. Economic stagnation has
led to problems with drug supply, as well as failure to pay medical personnel."

An infected person develops tuberculosis when stress to the victim such as
malnutrition, immune system dysfunction or disease allow the bacilli to
proliferate in the body, usually in the lungs. Poor sanitation, cramped living
conditions and an unchecked AIDS epidemic are also fuel for turning a carrier
of the microbe into an active TB case. It is then spread through the air when a
victim of the active disease coughs or sneezes, infecting others.

Better living standards for the urban masses and the growing science of
microbes and communicable disease led to significant declines in disease rates
in Europe even before antibiotics were developed. When anti-tuberculosis drugs
were discovered in the 1940s disease rates fell even faster. By the late 1960s
many believed the disease was on the verge of extinction.

Today the massive and completely unexpected rise in the former Soviet Union of
all three forms of tuberculosis—susceptible, drug-resistant and multidrug-
resistant—has been called an epidemiological Chernobyl, recalling the
eighteenth and nineteenth century European epidemics when the destructive
disease came to be called the white plague.

A section of the Harvard report focuses on prisons in Russia as a major
contributor to the tuberculosis crisis: "Russia and the United States are neck-
and-neck in the race for the highest per capita rates of detention. In the
context of social and economic turmoil, Russia has pulled ahead, with a
national incarceration rate of almost 700 per 100,000 population; in certain
regions, that number exceeds 1,000 per 100,000 population. Fully 29 percent of
convicted prisoners are younger than 25 years of age."

In 1999, over 98,000 inmates—almost 10 percent of all Russian prisoners—were
sick with tuberculosis. Some 80 percent of prisoners may already be infected
with some form of the bacteria. Disease rates greater than 3,000 per 100,000
prisoners in several oblasts have been reported. The rate of MDR-TB among
inmates with tuberculosis is 20 percent in some prisons.

The Russian prison system is described as "an epidemiological pump, releasing
into society tens of thousands of active TB cases and hundreds of thousands of
infected individuals every year." They found that “many detainees become
infected during pre-trial detention before they are ever convicted of a crime.”
Since 1985 the incidence of TB cases in Russians who work in direct contact
with TB patients tripled, to 702.7 per 100,000 in 1997. Federation-wide case
notification has more than doubled since 1991, to 82 per 100,000 in 1997.

The WHO report on multidrug resistance only surveyed two oblasts in the Russian
Federation, Ivanovo and Tomsk. Only 11 of the 22 countries with high levels of
tuberculosis were surveyed for drug resistance.

India and China

In several other populous countries only a few administrative units were
surveyed. India and China are two such examples. India has more cases of
tuberculosis than any country in the world, 1.8 million. China has an estimated
1.4 million cases. In the areas of these two countries that were included in
the WHO survey, WHO found high percentages of drug-resistant tuberculosis
cases.

Of the four Chinese provinces surveyed, the highest rates of drug-resistant TB
and MDR-TB were in Henan province, the most populous province in China. The
prevalence of any drug resistance among new TB cases was 35 percent, and ranged
around the already high rate of 15 percent in the other provinces surveyed.
Resistance in previously treated cases was the highest in the world in Henan
province. The rate of these types of cases, defined as anyone who received more
than one month of anti-tubercular medicine at any time in their life, was 66
percent. MDR-TB was found in 35 percent of previously treated cases in Zhejiang
Province, the highest rate among countries testing more than 100 of these
cases.

With the largest burden of TB in the world, India spends $3 billion on TB
prevention, diagnosis and control annually. Even so, over 400,000 people die
from TB in India each year. Because it usually strikes workers in the prime of
their lives, the resulting loss of a breadwinner's wages accounts for economic
hardship for millions more family members. Of Indian families who had a TB
sufferer, 75 percent living in urban areas went into debt fighting the disease.
WHO surveyed the state of Tamil Nadu and found another MDR-TB hot spot with 3.4
percent of new cases found to be multidrug resistant.

After China and India, Indonesia has the next highest overall TB burden, over
half a million. Drug resistance surveys are under way now in Indonesia. But
recent IMF-dictated cuts in the already crippled Indonesian health system will
further hamper efforts to document cases and to fight TB there.

WHO's other report entitled Global Tuberculosis Control Report 2000 is the
fourth to assess the world burden of tuberculosis since the agency declared the
disease a global emergency in the early part of the last decade. TB is now a
leading killer among infectious diseases. The new report surveys estimates of
TB infection and disease throughout the world and the results of WHO-sanctioned
control efforts in several countries.

The only country in Africa considered an MDR-TB hot spot is Mozambique, with
levels exceeding 3.5 percent in new cases. However, there are many African
countries on the WHO list of 22 high-burden countries. They include Ethiopia,
The Democratic Republic of the Congo, The United Republic of Tanzania, Kenya
and Uganda. Nigeria has 260,000 estimated cases of TB.

The highest rate of tuberculosis in the world is in Zimbabwe, with over 550
cases per 100,000 population. South Africa also had a high disease rate at
nearly 440 per 100,000 people in the country ill with tuberculosis.

The AIDS epidemic has had the effect of increasing overall TB rates, especially
in sub-Saharan Africa. Twenty-three million people in Saharan Africa are
infected with AIDS and over 5,000 new infections occur every day, according to
WHO. Eleven million people in the world are infected with both TB and HIV. HIV
infection is responsible for 15 percent of all new cases of TB. TB is also
counted as the single largest killer of people with HIV.

According to Global Tuberculosis Control Report 2000 the number of people with
access to the recommended treatment for tuberculosis named DOTS (or DOTS-plus
for drug-resistant areas) has doubled since 1995. Still, less than one in five
of the world's tuberculosis cases were treated with DOTS protocols in 1998. The
greatest number of TB patients without access to good treatment was where the
numbers were greatest, in Asia, particularly in Bangladesh, India, Indonesia,
Pakistan and the Philippines.

There is growing concern in official circles of the political impact of
infectious disease epidemics, particularly tuberculosis, malaria and HIV/AIDS.
The Open Society Institute hosted a conference of world leaders last year to
address the tuberculosis epidemic. George Soros, the billionaire investor and
anticommunist behind the institute, has provided funds to tuberculosis control
in Russia and Latin America.

The World Bank has also provided funds for tuberculosis and malaria control
projects through loans to several countries. The World Bank and WHO marked
World TB day in 2000 with a conference entitled TB and Sustainable Development.
Delegates included finance and health ministers from 20 of the 22 high burden
countries as well as UN representatives and US Health Secretary Donna Shalala.
Figures on the existing debt of these countries presented to the meeting were
staggering. In some African countries the total debt per capita is greater than
the annual Gross Domestic Product per capita. What can be the effect of the
paltry and shrinking amounts of aid and loans being provided by the capitalist
institutions for disease control on areas where staggering debt coupled with
falling commodity prices has already created massive poverty? These initiatives
are undertaken primarily by these capitalist concerns to protect their growing
transnational investments.

The fear of political upheaval resulting from unchecked disease was evident in
the decision of the Clinton administration to recently designate the global
spread of AIDS as a threat to US national security. Such a designation for any
infectious disease is unprecedented for the US government.

A National Intelligence Estimate prepared in January concluded a quarter of
southern Africa's population will die from AIDS and the number of people dying
from the disease will rise for a decade. In referring to the catastrophic death
rate from HIV/AIDS in Africa (despite the existence of life-saving drugs for
AIDS) they predicted that "at least some of the hardest-hit countries,
initially in sub-Saharan Africa and later other regions, will face a
demographic catastrophe. This will further impoverish the poor and often the
middle class and produce a huge and impoverished orphan cohort unable to cope
and vulnerable to exploitation and radicalization."

Copyright 1998-2000
World Socialist Web Site
All rights reserved

A<>E<>R
~~~~~~~~~~~~~~~
Integrity has no need of rules. -Albert Camus (1913-1960)
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
The only real voyage of discovery consists not in seeking
new landscapes but in having new eyes. -Marcel Proust
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
"Believe nothing, no matter where you read it, or who said
it, no matter if I have said it, unless it agrees with your
own reason and your common sense." --Buddha
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
It is preoccupation with possessions, more than anything else, that
prevents us from living freely and nobly. -Bertrand Russell
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
"Everyone has the right...to seek, receive and impart
information and ideas through any media and regardless
of frontiers." Universal Declaration of Human Rights
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
"Always do sober what you said you'd do drunk. That will
teach you to keep your mouth shut." Ernest Hemingway
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
Forwarded as information only; no endorsement to be presumed
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
In accordance with Title 17 U.S.C. section 107, this material
is distributed without charge or profit to those who have
expressed a prior interest in receiving this type of information
for non-profit research and educational purposes only.

<A HREF="http://www.ctrl.org/">www.ctrl.org</A>
DECLARATION & DISCLAIMER
==========
CTRL is a discussion & informational exchange list. Proselytizing propagandic
screeds are unwelcomed. Substance—not soap-boxing—please!  These are
sordid matters and 'conspiracy theory'—with its many half-truths,
misdirections
and outright frauds—is used politically by different groups with major and
minor
effects spread throughout the spectrum of time and thought. That being said,
CTRL
gives no endorsement to the validity of posts, and always suggests to readers;
be wary of what you read. CTRL gives no credence to Holocaust denial and
nazi's need not apply.

Let us please be civil and as always, Caveat Lector.
========================================================================
Archives Available at:
http://home.ease.lsoft.com/archives/CTRL.html
<A HREF="http://home.ease.lsoft.com/archives/ctrl.html">Archives of
[EMAIL PROTECTED]</A>

http:[EMAIL PROTECTED]/
 <A HREF="http:[EMAIL PROTECTED]/">ctrl</A>
========================================================================
To subscribe to Conspiracy Theory Research List[CTRL] send email:
SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]

To UNsubscribe to Conspiracy Theory Research List[CTRL] send email:
SIGNOFF CTRL [to:] [EMAIL PROTECTED]

Om

Reply via email to